Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Clinical trial NCT05681780 · RECRUITING

Trial details

NCT number: NCT05681780
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Recurrent Non Small Cell Lung Cancer

Start date: 2023-03-10
Primary completion: 2026-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.